These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20033412)

  • 21. Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept.
    Maeshima K; Ishii K; Iwakura M; Akamine M; Hamasaki H; Abe I; Haranaka M; Tatsukawa H; Yoshimatsu H
    Mod Rheumatol; 2012 Feb; 22(1):137-41. PubMed ID: 21670967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult-Onset Still's Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms.
    Maranini B; Ciancio G; Govoni M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission.
    Giacomelli R; Caporali R; Ciccia F; Colafrancesco S; Dagna L; Govoni M; Iannone F; Leccese P; Montecucco C; Pappagallo G; Pistone G; Priori R; Ruscitti P; Sfriso P; Cantarini L;
    Autoimmun Rev; 2023 Dec; 22(12):103400. PubMed ID: 37482365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients.
    Kokkinos A; Iliopoulos A; Greka P; Efthymiou A; Katsilambros N; Sfikakis PP
    Clin Rheumatol; 2004 Feb; 23(1):45-9. PubMed ID: 14749983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adding colchicine to immunosuppressive treatments; a potential option for biologics-refractory adult-onset Still's disease.
    Asano T; Furuya MY; Sato S; Kobayashi H; Watanabe H; Suzuki E; Migita K
    BMC Res Notes; 2018 May; 11(1):320. PubMed ID: 29784018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
    Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Caso F; Perosa F; Atzeni F; Cantatore FP; Scarpa R; Ciccia F; Giacomelli R
    Rheumatol Int; 2020 Jan; 40(1):107-113. PubMed ID: 31263993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult-onset Still's disease complicated with hemophagocytic syndrome.
    Yeh HM; Liu MF; Chang KK; Liu SM; Chen CH
    J Formos Med Assoc; 2010 Jan; 109(1):85-8. PubMed ID: 20123591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of tacrolimus for refractory adult-onset still's disease: Report of six cases.
    Nakamura H; Odani T; Shimizu Y; Takeda T; Kikuchi H
    Mod Rheumatol; 2016 Nov; 26(6):963-967. PubMed ID: 25036233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of refractory adult-onset Still's disease treated with anakinra.
    Lahiri M; Teng GG
    Int J Rheum Dis; 2010 Aug; 13(3):e36-41. PubMed ID: 20704609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult-onset Still's disease: Advances in the treatment.
    Castañeda S; Blanco R; González-Gay MA
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate treatment in patients with adult onset Still's disease--retrospective study of 13 Japanese cases.
    Fujii T; Akizuki M; Kameda H; Matsumura M; Hirakata M; Yoshida T; Shinozawa T; Mimori T
    Ann Rheum Dis; 1997 Feb; 56(2):144-8. PubMed ID: 9068291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
    Fautrel B; Borget C; Rozenberg S; Meyer O; Le Loët X; Masson C; Koeger AC; Kahn MF; Bourgeois P
    J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent plaques and linear pigmentation in adult-onset Still's disease.
    Suzuki K; Kimura Y; Aoki M; Takezaki S; Tuchida T; Takano T; Kawana S
    Dermatology; 2001; 202(4):333-5. PubMed ID: 11455148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of methotrexate in adult-onset Still's disease.
    Manger B; Rech J; Schett G
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S168-71. PubMed ID: 21044454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult onset Still's disease: experience from a tertiary care rheumatology unit.
    Reddy Munagala VV; Misra R; Agarwal V; Lawrence A; Aggarwal A
    Int J Rheum Dis; 2012 Dec; 15(6):e136-41. PubMed ID: 23253241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult-onset Still's disease with atypical cutaneous manifestations.
    Narváez Garcia FJ; Pascual M; López de Recalde M; Juarez P; Morales-Ivorra I; Notario J; Jucglà A; Nolla JM
    Medicine (Baltimore); 2017 Mar; 96(11):e6318. PubMed ID: 28296747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review.
    Reihl Crnogaj M; Čubelić D; Babić A; Mayer M; Anić B
    Rheumatol Int; 2020 Aug; 40(8):1317-1325. PubMed ID: 32506202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent pruritic papules and plaques: a characteristic histopathologic presentation seen in a subset of patients with adult-onset and juvenile Still's disease.
    Fortna RR; Gudjonsson JE; Seidel G; Dicostanzo D; Jacobson M; Kopelman M; Patel RM
    J Cutan Pathol; 2010 Sep; 37(9):932-7. PubMed ID: 20546088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.
    Gabay C; Fautrel B; Rech J; Spertini F; Feist E; Kötter I; Hachulla E; Morel J; Schaeverbeke T; Hamidou MA; Martin T; Hellmich B; Lamprecht P; Schulze-Koops H; Courvoisier DS; Sleight A; Schiffrin EJ
    Ann Rheum Dis; 2018 Jun; 77(6):840-847. PubMed ID: 29472362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.